HLB Co., Ltd. (KOSDAQ:028300)
South Korea · Delayed Price · Currency is KRW 44,550
+3,350 (8.13%)
Oct 21, 2025, 1:40 PM KST
HLB Co., Ltd. Market Cap
HLB Co., Ltd. has a market cap or net worth of 5.41 trillion as of October 20, 2025. Its market cap has decreased by -53.08% in one year.
Market Cap
5.41T
Enterprise Value
5.55T
Revenue
75.57B
Ranking
n/a
PE Ratio
n/a
Stock Price
44,550.00
Market Cap Chart
Since December 24, 2008, HLB Co., Ltd.'s market cap has increased from 13.46B to 5.41T, an increase of 40,060.23%. That is a compound annual growth rate of 42.81%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 17, 2025 | 5.22T | -45.53% |
| Dec 30, 2024 | 9.59T | 46.53% |
| Dec 28, 2023 | 6.54T | 98.02% |
| Dec 29, 2022 | 3.30T | -10.84% |
| Dec 30, 2021 | 3.71T | -24.18% |
| Dec 30, 2020 | 4.89T | -0.25% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 79.50T |
| Celltrion | 38.55T |
| ALTEOGEN | 23.16T |
| Yuhan | 8.73T |
| SK Biopharmaceuticals | 7.91T |
| Peptron | 5.91T |
| PharmaResearch | 5.74T |
| LigaChem Biosciences | 4.79T |